While higher YBEY expression appears to be beneficial in overall survival analyses, these data may be skewed due to the higher number of earlier stage breast cancers in TCGA or potentially confounded by estrogen receptor status, as observed in our survival analysis. The gene discussed is YBEY; the disease is breast carcinoma.